Funding for this research was provided by:
H2020 European Research Council (720776)
Article History
Received: 8 October 2020
Accepted: 7 January 2021
First Online: 1 February 2021
Ethics approval and consent to participate
: Not applicable.
: All authors agree to publishing this manuscript with Microbial Cell Factories.
: JM and GS have filed a patent on the reported enGenes-X-press technology [PCT/EP2016/059597] and own interests in enGenes Biotech. enGenes Biotech is the legal entity commercializing the reported technology.